FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/12/2024
Voltar para busca
Dado oficial do USPTO
LEMONEX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LEMONEX
ST13
US500000079323387Classe
35, 40, 42, 44
Pedido
79323387
Registro
7361950
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
07/12/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 40, 42, 44
Data de depósito
26/08/2021
Data de registro
23/04/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/04/2024
Última transação
23/04/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
01
Localização do titular
KR
Examinador
MASON, JARED MICHAEL
Unidade examinadora
N10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
WON, Cheol Hee
Representantes
Jong Park The PL Law Group, PLLC
Classificação técnica
Classes Nice
Classe 35Classe 40Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Wholesale store services featuring diagnostic apparatus for medical use; sales agency servicesretail services by direct solicitation by sales agents featuring diagnostic apparatus for medical use; wholesale store services featuring diagnostic preparations for medical or veterinary purposes; wholesale store services featuring reagents for medical use; wholesale store services featuring cosmetics; wholesale store services featuring diagnostic reagents for pharmaceutical purposes; wholesale store services featuring synthetic peptides for pharmaceutical purposes; sales agency servicesretail services by direct solicitation by sales agents featuring for pharmaceuticals; wholesale store services featuring pharmaceutical preparations for diagnosis; sales agency servicesretail services by direct solicitation by sales agents featuring for medical apparatus and instruments; sales agency servicesretail services by direct solicitation by sales agents featuring for medicated mouth care and treatment preparations; sales agency servicesretail services by direct solicitation by sales agents featuring for masks for medical purposes; wholesale store services featuring chemical reagents for medical or veterinary purposes; wholesale store services featuring biological preparations for medical purposes; sales agency servicesretail services by direct solicitation by sales agents featuring for testing apparatus for medical purposes; sales agency servicesretail services by direct solicitation by sales agents featuring for balmsother than for medical purposes; sales agency servicesretail services by direct solicitation by sales agents featuring for non-medicated mouthwashes; sales agency servicesretail services by direct solicitation by sales agents featuring for aerosol dispensersnot for medical purposes
Classe 40
Processing of chemical reagents; processing of pharmaceutical preparations; preservation of pharmaceuticals; custom manufacture of medical devices for others; custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; custom manufacture of pharmaceuticals; processing of medicinal materials; processing of foodstuffs for use in manufacture
Classe 42
Scientific research and development of amino acid for medical purpose; scientific research and development of peptide for medical purposes; scientific research for medical purposes; scientific development of cell therapy products; clinical studies of medicinesscientific research in the nature of conducting clinical trials of medicines for others; medical research; drug discovery services; pharmaceutical research and development; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; scientific cosmetics development services; DNA screening for scientific research purposes; research relating to biotechnology; biotechnology consulting services; scientific research and development of chemical amino acids; scientific research and development of DNA chips; scientific development of biologics; character designanimation design for others
Classe 44
Preparation and dispensing of medications; provision of dietary food supplements for medical purposes being dispensing of medications; providing medical supplements for medical purposes being dispensing of medications; providing nutritional supplements for medical purposes being dispensing of medications; providing vitamin for medical purposes being dispensing of medications; medical and health services relating to DNAgenetics and genetic testingDNA and genetic testing for medical purposes; medical analysis for the diagnosis and treatment of persons; laboratory analysis services relating to the treatment of personsmedical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical services relating to the removaltreatment and processing of human bloodumbilical cord bloodhuman cellsstem cells and bone marrow; medical analysis services for cancer diagnosis and prognosis; medical analysis services for the diagnosis of cancer; medical services in the field of oncology; medical services relating to the removaltreatment and processing of stem cells; medical testing services relating to the diagnosis and treatment of disease; medical care and analysis services relating to patient treatment; medical screening; medical services relating to the removaltreatment and processing of human cells; analysis of human tissues for medical treatment; analysis of human serum for medical treatment; provision of gene therapy for medical treatment purposes; provision of genetic information for medical treatment purposes; provision of genetic testing for medical treatment purposes; genetic testing of animals for diagnostic or treatment purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
22/10/2024
XXCR
GENERIC MADRID TRANSACTION CREATED
21/10/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/07/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
23/04/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
23/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/02/2024
PUBO
PUBLISHED FOR OPPOSITION
06/02/2024
GPNX
NOTIFICATION PROCESSED BY IB
05/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/01/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/01/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
05/12/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/03/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
22/03/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/07/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
25/07/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
25/07/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
25/07/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
25/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/07/2022
RFNP
REFUSAL PROCESSED BY IB
19/07/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/06/2022
RFRR
REFUSAL PROCESSED BY MPU
23/06/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/06/2022
CNRT
NON-FINAL ACTION WRITTEN
02/06/2022
DOCK
ASSIGNED TO EXAMINER
31/05/2022
MAFR
APPLICATION FILING RECEIPT MAILED
29/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/10/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/10/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LEMONEX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.